Metastatic melanoma cell. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy14

Melanocytes Cell Line, Tumor Tumor Cells, Cultured Lymphocytes, Tumor-Infiltrating Neoplastic Cells, Circulating T-Lymphocytes, Cytotoxic Cell Line Clone Cells Lymph Nodes CD8-Positive T-Lymphocytes T-Lymphocytes Skin Cells, Cultured Killer Cells, Natural

Organisms3

Mice, Nude Mice, Inbred C57BL Mice, SCID

Diseases19

Melanoma Skin Neoplasms Melanoma, Experimental Neoplasm Metastasis Nevus Neoplasm Invasiveness Uveal Neoplasms Nevus, Pigmented Disease Progression Melanoma, Amelanotic Choroid Neoplasms Dysplastic Nevus Syndrome Eye Neoplasms Lymphatic Metastasis Lung Neoplasms Vitiligo Neoplastic Cells, Circulating Brain Neoplasms Neovascularization, Pathologic

Chemicals and Drugs47

MART-1 Antigen Neoplasm Proteins Dacarbazine gp100 Melanoma Antigen Proto-Oncogene Proteins B-raf Monophenol Monooxygenase Antineoplastic Agents Melanoma-Specific Antigens Antigens, Neoplasm Melanins RNA, Messenger Cancer Vaccines Microphthalmia-Associated Transcription Factor Interleukin-2 Antibodies, Monoclonal Antigens, CD146 Interferon-alpha alpha-MSH HLA-A2 Antigen Tumor Markers, Biological Sulfonamides CTLA-4 Antigen Antineoplastic Agents, Alkylating Cysteinyldopa Recombinant Proteins Gangliosides Indoles Antigens, CD Cisplatin Membrane Glycoproteins Antibodies, Neoplasm Melanocyte-Stimulating Hormones RNA, Small Interfering Oximes S100 Proteins DNA, Neoplasm HLA-A Antigens Vinblastine RNA, Neoplasm Receptor, Melanocortin, Type 1 Granulocyte-Macrophage Colony-Stimulating Factor Intramolecular Oxidoreductases Protein Kinase Inhibitors Proto-Oncogene Proteins c-kit Proto-Oncogene Proteins c-bcl-2 Interferon-gamma Benzenesulfonates

Analytical, Diagnostic and Therapeutic Techniques and Equipment31

Melanoma, Experimental Neoplasm Transplantation Immunohistochemistry Immunotherapy Immunotherapy, Adoptive Treatment Outcome Neoplasm Staging Antineoplastic Combined Chemotherapy Protocols Reverse Transcriptase Polymerase Chain Reaction Flow Cytometry Survival Analysis Injections, Intralesional Transplantation, Heterologous Prognosis Transfection Immunotherapy, Active Drug Screening Assays, Antitumor Blotting, Western Survival Rate Sentinel Lymph Node Biopsy Disease-Free Survival Xenograft Model Antitumor Assays Injections, Subcutaneous Drug Administration Schedule Eye Enucleation Combined Modality Therapy Pigmentation Tumor Burden Monitoring, Immunologic Gene Expression Profiling Molecular Targeted Therapy

Phenomena and Processes21

Gene Expression Regulation, Neoplastic Apoptosis Cell Movement Cell Adhesion Cell Proliferation Cell Division Signal Transduction Cell Survival Transfection Down-Regulation Mutation Cytotoxicity, Immunologic Drug Resistance, Neoplasm Time Factors Up-Regulation Dose-Response Relationship, Drug Base Sequence Pigmentation Cell Cycle Drug Synergism Phenotype

Disciplines and Occupations1

Immunohistochemistry

Information Science3

Survival Rate Molecular Sequence Data Base Sequence

Health Care4

Treatment Outcome Survival Analysis Survival Rate Disease-Free Survival

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Information Science Health Care

Melanoma Skin Neoplasms Melanoma, Experimental Melanocytes Neoplasm Metastasis MART-1 Antigen Cell Line, Tumor Nevus Tumor Cells, Cultured Neoplasm Invasiveness Neoplasm Proteins Gene Expression Regulation, Neoplastic Neoplasm Transplantation Dacarbazine gp100 Melanoma Antigen Uveal Neoplasms Proto-Oncogene Proteins B-raf Monophenol Monooxygenase Mice, Nude Antineoplastic Agents Apoptosis Nevus, Pigmented Cell Movement Disease Progression Cell Adhesion Melanoma-Specific Antigens Antigens, Neoplasm Cell Proliferation Melanoma, Amelanotic Immunohistochemistry Melanins Cell Division Signal Transduction RNA, Messenger Lymphocytes, Tumor-Infiltrating Cancer Vaccines Choroid Neoplasms Dysplastic Nevus Syndrome Immunotherapy Microphthalmia-Associated Transcription Factor Interleukin-2 Immunotherapy, Adoptive Antibodies, Monoclonal Antigens, CD146 Interferon-alpha alpha-MSH Treatment Outcome HLA-A2 Antigen Eye Neoplasms Lymphatic Metastasis Tumor Markers, Biological Sulfonamides CTLA-4 Antigen Neoplasm Staging Antineoplastic Agents, Alkylating Antineoplastic Combined Chemotherapy Protocols Cysteinyldopa Reverse Transcriptase Polymerase Chain Reaction Lung Neoplasms Mice, Inbred C57BL Flow Cytometry Survival Analysis Recombinant Proteins Gangliosides Injections, Intralesional Cell Survival Transplantation, Heterologous Indoles Antigens, CD Vitiligo Prognosis Cisplatin Neoplastic Cells, Circulating Membrane Glycoproteins Antibodies, Neoplasm Melanocyte-Stimulating Hormones Transfection Immunotherapy, Active T-Lymphocytes, Cytotoxic Down-Regulation Drug Screening Assays, Antitumor RNA, Small Interfering Brain Neoplasms Oximes Mutation Cytotoxicity, Immunologic S100 Proteins Drug Resistance, Neoplasm Blotting, Western Cell Line Survival Rate Sentinel Lymph Node Biopsy Disease-Free Survival Clone Cells Xenograft Model Antitumor Assays Injections, Subcutaneous Molecular Sequence Data DNA, Neoplasm Time Factors Drug Administration Schedule

No FAQ available that match "metastatic melanoma cell"